Hemosiderin deposits confounds tracking of iron-oxide-labeled stem cells: an experimental study

Area of Science:

• Biomedical research
• Stem cell therapy
• Cardiovascular science

Background:

• Assessing the efficacy of mesenchymal stem cell (MSC) therapy requires reliable methods for tracking cell distribution.
• Iron-labeled MSCs are a potential tool for tracking, but their detection may be affected by endogenous tissue components.
• Hemosiderin, an iron storage complex, can accumulate in tissues following hemorrhage, such as in myocardial infarction.

Purpose of the Study:

• To investigate whether hemosiderin deposits interfere with the histological detection of dextran-coated, iron-labeled MSCs.
• To evaluate the utility of iron labeling for tracking MSCs in a porcine model of myocardial infarction.

Main Methods:

• Myocardial infarction was induced in pigs, followed by intracoronary administration of iron-labeled MSCs or placebo.
• Control pigs without infarction received intramyocardial injections of iron-labeled MSCs or placebo.
• Histological sections were stained with Prussian blue to detect iron-labeled MSCs.

Main Results:

• Granular blue labeling, indicative of iron, was observed in infarct regions of animals receiving iron-labeled MSCs.
• Similar blue labeling was present in control animals that received iron-labeled MSCs.
• No blue labeling was observed in control animals that received placebo, confirming specificity of the iron label itself.

Conclusions:

• Hemosiderin deposits resulting from infarction-related hemorrhage significantly interfere with the Prussian blue detection of iron-labeled MSCs.
• The current iron-labeling and Prussian blue staining method is unreliable for tracking MSCs in the context of myocardial infarction in this model.
• Alternative tracking methods may be necessary for evaluating MSC delivery and engraftment in myocardial infarction studies.